Inovio Pharmaceuticals Inc (NASDAQ:INO) - Share price - Overview

Stock Report

Inovio Pharmaceuticals Inc INO

Last Price
$5.55

Day Change
-0.01|-0.18%

As of 23/08/2017
16:06:03 EDT | USD
Minimum 15 Minutes Delay.

Last Close5.56
Day Range5.50 - 5.64
Mkt Cap500.80Mil
52-Wk Range5.28 - 9.86
Yield %-
ISINUS45773H2013
Volume732,762
P/E-5.14
P/S7.96
P/CF-6.30

Share Price

Financials
201420152016
More ...
Income Statement
Revenue10.4640.5735.37
Operating Income-39.50-34.28-76.24
Net Income-36.12-29.19-73.74
Basic EPS-0.61-0.43-1.01
Avg. Diluted Shares Outstanding596873
Balance Sheet
Current Assets98.95171.85124.60
Non Current Assets32.8441.9949.11
Total Assets131.79213.84173.71
Current Liabilities14.0231.4743.82
Total Liabilities20.5638.1550.43
Total Equity111.23175.69123.28
Cash Flow
Operating Cash Flow-29.82-12.44-62.56
Capital Expenditure--2.78-3.94
Free Cash Flow--15.22-66.49

In millions, except "Basic EPS". Currency is USD.

Company Profile

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

239
Key Stats
More ...
Price/Earning TTM-5.15
Price/Book4.06
Price/Sales TTM10.89
Rev Growth (3 year avg)37.97
EPS Growth (3 year avg)-
Operating Margin % TTM-215.55
Net Margin % TTM-208.49
ROE TTM-49.33
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.